loader
Please Wait
Applying Filters...

Annual Sales of Rifaximin reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 235Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Xifaxan

PharmaCompass

01

Brand Name : Xifaxan

Rifaximin

arrow
Discovery on Target
Not Confirmed

Brand Name : Xifaxan

arrow
Discovery on Target
Not Confirmed

Rifaximin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,482

2019 Revenue in Millions : 1,452

Growth (%) : 2

blank

02

Brand Name : Xifaxan

Rifaximin

arrow
Discovery on Target
Not Confirmed

Brand Name : Xifaxan

arrow
Discovery on Target
Not Confirmed

Rifaximin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 1,645

2020 Revenue in Millions : 1,482

Growth (%) : 11

blank

03

Brand Name : Xifaxan

Rifaximin

arrow
Discovery on Target
Not Confirmed

Brand Name : Xifaxan

arrow
Discovery on Target
Not Confirmed

Rifaximin

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 1,452

2018 Revenue in Millions : 1,195

Growth (%) : 22

blank